If you’ve come away from a GP or respiratory clinic appointment with a nebuliser referral, or you’re wondering whether one might work better than the inhaler you’ve been using for years, the honest answer is that the NHS doesn’t treat the two as interchangeable options you pick by preference. They deliver medicine differently, they’re prescribed for different reasons, and understanding which situations call for which device is worth ten minutes before you spend money or NHS resources on either.
This is the kind of question a consumer watchdog exists to answer plainly: not by recommending a specific product, but by setting out what the actual clinical reasoning is, so you can have a more informed conversation with whoever prescribes or reviews your treatment.
What Actually Happens Inside Each Device
A standard inhaler, usually a metered dose inhaler (MDI), releases a precisely measured spray of medicine in a single puff. It’s compact, portable and near-instant, but it demands coordination: you have to trigger the device and inhale at the same moment for the dose to reach your lungs rather than the back of your throat. A spacer (a plastic chamber that fits over the inhaler) removes most of that timing problem and is the NHS’s default recommendation alongside an inhaler for exactly this reason.
A nebuliser works on a completely different principle. It’s an electric machine that turns liquid medicine, poured from a single-dose vial or nebule, into a continuous fine mist. You breathe that mist in normally through a mouthpiece or mask over roughly five to ten minutes. There’s no button to press in time with your breath and no coordination required, but the device itself is bulkier, needs a power source, and takes considerably longer to use than a couple of puffs from an inhaler.
When Clinicians Reach for a Nebuliser Instead
According to NHS guidance, nebulisers tend to come into the picture in a specific set of circumstances, not as a general upgrade from an inhaler. The clearest case is an acute, severe asthma attack or a COPD flare-up, where a nebuliser can deliver a higher dose of medicine quickly, and oxygen is sometimes used as the driving gas for nebulised salbutamol in emergency settings. Outside of an acute episode, a nebuliser is more likely to be arranged for home use when someone genuinely struggles with inhaler technique, even with a spacer, including some children, some elderly patients, and people with certain physical or cognitive comorbidities that make timed inhalation difficult. It’s also considered when handheld inhalers have proven ineffective for someone with chronic lung disease, when a larger dose of medicine is needed than an inhaler can practically deliver, or for specific medicines, such as certain antibiotics or saline solutions used to loosen mucus, that are formulated for nebuliser use rather than an inhaler. Long-term conditions such as cystic fibrosis or bronchiectasis are a further category where home nebulisers are commonly arranged as part of ongoing management, and for COPD specifically, a nebuliser may be considered when someone has distressing or disabling breathlessness despite being on maximum inhaler therapy.
Why Inhalers Remain the First Choice for Most People
For routine, day-to-day management of asthma or COPD, NHS guidance and the UK’s leading respiratory charity are consistent that an inhaler, used correctly with a spacer, is the preferred option, and most asthma attacks and flare-ups can be treated effectively with a reliever inhaler at home. Nebulisers see more routine use in emergency settings, such as A&E, ambulances and acute hospital wards, than as a first-line home treatment for otherwise well-controlled asthma. Where home nebuliser use for asthma is considered, it’s generally reserved for people at higher risk of severe attacks or who have already been shown to struggle with inhaler technique, and the decision is meant to follow a full clinical assessment rather than personal preference. For COPD, the same logic applies: nebulised medicine at home is something a clinician may introduce in more severe cases where inhalers alone aren’t managing symptoms, with training provided on safe use.
| Factor | Inhaler (with spacer) | Nebuliser |
|---|---|---|
| Typical dose per use | Fixed, measured puff(s) | Can deliver a larger dose in one session |
| Time to administer | Seconds per puff | Roughly 5-10 minutes per session |
| Coordination needed | Reduced with a spacer, still some technique required | None; normal breathing is enough |
| Portability | Pocket-sized, no power needed | Bulkier, usually needs mains or battery power |
| Typical NHS role | First-line, daily management | Acute episodes, or specific home-use cases assessed individually |
Questions Worth Asking Before You Take a Nebuliser Home
If a nebuliser has been suggested or prescribed for home use, it’s reasonable to ask a few plain questions rather than simply accepting the equipment. Is the nebuliser intended for daily maintenance treatment, or only for use during a flare-up? What specific medicine or nebule is it prescribed to deliver, and would that medicine work in an inhaler instead? Has inhaler technique, including use of a spacer, actually been reassessed and ruled out as sufficient before moving to a nebuliser? And practically: who is responsible for servicing the machine, replacing the mouthpiece or mask, and covering any running costs, since NHS provision of home nebulisers and consumables varies by area and by clinical need. None of these questions is about second-guessing a clinician’s judgement; they’re about making sure a genuinely useful piece of home medical equipment is being used for the reason it was actually prescribed.
The Bottom Line
Neither device is simply “better” than the other in every case; a nebuliser and an inhaler solve different problems. The nebuliser vs inhaler decision, when it’s made properly, comes down to how severe and how frequent your symptoms are, whether you can manage inhaler technique even with a spacer, and what specific medicine you need delivered. If you’re unsure why you’ve been offered one over the other, that’s a fair and useful question to put back to whoever prescribed it.